Introduction: The effectiveness of hyperbaric
pedal levels had no relation to outcomes, while the average scores of the femoral arterial level affected the results (P = 0.048).
Conclusions: Diabetic foot patients with histories of coronary artery diseases or stroke and non-proliferative or proliferative retinopathy might resist HBOT. PAD at the femoral arterial level has been shown to have a significant negative effect on HBOT outcomes that should be first considered for surgery. In contrast, PAD below the knee does not seem to be an obstacle to the efficacy of HBOT. 
INTRODUCTION
Diabetic foot is a worldwide problem that causes morbidity and mortality together with high costs. Nearly 20% of ulcers are reported as non-healing despite standard care [1, 2] . Hyperbaric oxygen therapy (HBOT) is a systemic method to provide extra oxygen to tissues. This therapy achieves sufficient oxygen concentrations for infected hypoxic tissues, and can therefore be added to the treatment of problematic wounds, such as diabetic foot [3] .
HBOT enhances neutrophil killing ability and the effect of antibiotics, fibroblast activity, collagen synthesis, and stimulates angiogenesis [4] . Although this treatment is recommended with moderate-quality evidence [5, 6] , the effectiveness of HBOT on selected diabetic foot wounds still encounters controversy partly because of a history of unsubstantiated claims of its effectiveness in treating a variety of ailments [7] . The complexities of diabetes itself and also of the wounds make prospective, double blind, randomized-controlled trials difficult [1] . There are a few studies including prospective controlled trials on the use of HBOT in diabetic foot [8] [9] [10] [11] [12] [13] . The conclusions might be confusing depending on the characteristics of the wounds or the patients with different weighted complications.
The authors of the current study planned to retrospectively evaluate the effect of HBOT on the diabetic foot problem on a wide range of complicated patients. The aim was to discover the role of comorbidities as limiting factors on the effect of hyperbaric oxygen in cases of diabetic foot and to access the clinical data that may support that knowledge. Outcomes were analyzed at the end of HBOT depending on the available macrovascular and microvascular data. These outcomes were also compared with the 12th month results. Peripheral arterial disease (PAD), which was determined by color Doppler ultrasonography (DUS) and/or by angiographies, was analyzed. A modified scoring system was created to provide a numerical analysis of these tests, depending on previously reported assessment methods [15] [16] [17] .
METHODS
The schemes determining the levels and occlusion degrees within the recommended standards for reports dealing with lower extremity ischemia were utilized to assess the angiographic data of the current study [15] . DUS data were scored depending on the arterial flow characteristics. Furthermore, angiographic scoring degrees were inverted to synchronize the values obtained from color DUS data as follows.
Patients who had triphasic waveforms or normal calibration in all arteries from the aorta to the dorsal pedal artery were accepted to be free of PAD, while others were considered to have PAD. Triphasic waveforms on color DUS and/or normal calibration in angiography were scored as 3 points. Biphasic waveform and/or stenosis greater than 50% was scored as 2 points; monophasic waveform and/or circulation by collateral arteries was scored as 1 point. If there was a total occlusion, it was scored as 0 points. Scores were recorded for each artery from the aorta to dorsal the pedal artery.
The average scores of these data were also calculated in four levels as follows: 1. Aorto-iliac (abdominal aorta, common, and external iliac arterial scores). The relationship of PAD to wound healing of HBOT-treated patients was evaluated depending on these scores. These patients were also evaluated on their vascular interventions which were decided by surgeons that the patients consulted. 
RESULTS
One hundred and seventeen patients were reviewed, nine of which were readmitted to the hyperbaric center at least 1 year later because of a subsequent wound and these patients were counted twice. Therefore, 126 diabetic foot lesions were evaluated. There were 84 Wagner grade 3, 41 grade 4, and one grade 5 diabetic foot lesions assessed. Of these wounds, 68 (54.0%) were ischemic, six (4.8%) were neuroischemic, 40 (31.7%) were neuropathic non-ischemic, and 12 (9.5%) were neither ischemic nor neuropathic.
The mean age of patients was 59. Most of the patients with PAD were not operated on because a lack of optimal vascular interventions. Among these 51 non-operated patients, 21 (41.2%) had atherosclerotic changes placed below the knee, 30 (58.8%) had these changes placed both above and below the knee (Fig. 1) . Depending on the modified scoring system, no significant relationship between the outcomes and the arterial scorings was found when each artery was evaluated singly.
However, when considered by average scorings of four levels (aorto-iliac, femoral, popliteal, and pedal), only the average of the femoral arterial scores significantly affected the results (P = 0.048, Table 3 ). The mean value of femoral arterial scores was 2.77 ± 0.5 (median 3, min 1, max 3) in the first (favorable) group and 2.64 ± 0.4 (median 2.67, min 1, max 3) in the second (unfavorable) group.
The effect of microangiopathic complications on the outcomes was also studied separately. Advanced retinopathy significantly affected the outcomes (P = 0.022, Table 4 ). However, when nephropathy was analyzed in three groups (normoalbuminuria, microalbuminuria, and later stages) or in two groups (end-stage renal disease and others), it had no relation to the outcomes (P = 0.423 and P = 0.060, respectively). Similarly, neuropathy (P = 0.706) had no relation to the outcomes. n number, HBOT hyperbaric oxygen therapy a There were no statistically significant differences for wound healing results at completion of HBOT and at the 12th month (P = 0.214) Fig. 1 Peripheral arterial condition of patients who have angiographic and/or color DUS data. PAD was determined by color DUS and/or by angiographies. DUS Doppler ultrasonography data, HBO hyperbaric oxygen, PAD peripheral arterial disease, PTA percutaneous transluminal angioplasty
DISCUSSION
There are a few prospective controlled trials about HBOT usage on diabetic foot. Although conclusions are different in these studies, each of them has been focused on different types of wounds and patients [8] [9] [10] [11] [12] . The authors of the current study retrospectively evaluated the effect of HBOT on diabetic foot wounds in a wide range of patients with varying complications. The aim was to discover the factors that affect the outcome of HBOT and to understand the factors determining its efficacy.
Peripheral arterial disease is a known risk factor for limb amputation in patients with diabetes [18] [19] [20] . Angiographic and Doppler US scoring are reported as assessment methods to estimate the degree of PAD [15] [16] [17] . In the present study, the researchers modified these methods and evaluated the data of color DUSs and/or angiographies of 86 patients. Although ankle: brachial pressure scorings were shown to be in close correlation with arteriographic scorings [16] , the researchers preferred to use the flow characteristics of the arterial DUS data because of the unreliability of the Dopplerderived ankle: brachial index depending on arterial media calcification of diabetic vascular disease [21] . Furthermore, angiographic scoring degrees were inverted to synchronize the values obtained from color DUS. These modifications allowed the assessments to be made together or There was a significant relation of outcomes to retinopathy at the end of HBOT (P = 0.022) HBOT hyperbaric oxygen therapy, NPDR non-proliferative diabetic retinopathy, PDR proliferative diabetic retinopathy separately by the two different methods providing anatomic and hemodynamic information. Among the 51 non-operated PAD patients of the current study, 21 (41%) had atherosclerotic changes placed below the knee, 30 (58%) had these changes placed both above and below the knee (Fig. 1 ) in accordance to atherosclerosis of diabetes [22, 23] .
The present study used the arterial scorings of these patients to compare the PAD conditions and outcomes of those who were treated with HBOT. The scorings of each artery from the aorta to the pedal arteries were not associated with the outcomes. Although not significant, the P values related to the superficial femoral and posterior tibial arterial scorings (P = 0.070, P = 0.069, respectively) were distinctly lower than other single arteries (Table 3) . On the other hand, depending on the average scorings of the four arterial levels, the results demonstrate that there is a significant relationship to HBOT outcomes at the femoral arterial level (P = 0.048, Table 3 ), but not at the others. This suggests that wherever atherosclerotic changes were placed, only the femoral arterial locations affect the outcomes of HBOT negatively. Therefore, in the presence of femoral atherosclerotic lesions, attention must be given to vascular interventions before HBOT is initiated. In contrast, PAD below the knee does not seem to be an obstacle to the efficacy of HBOT in the treatment of diabetic foot.
PAD is an expression of systemic atherosclerotic disease. Therefore, the researchers of the current study evaluated the patients' histories of coronary artery disease, hypertension, stroke, and smoking habits to assess the other data related to atherosclerosis. A history of coronary artery disease and stroke has been demonstrated to worsen wound healing of the diabetic foot patients treated with HBOT (P = 0.002 and P = 0.015, respectively). This is true about coronary artery disease, regardless of HBOT [1, 24] . Faglia et al. [25] demonstrated prior instances of stroke to be a prognostic determinant of major amputation in patients treated with or without HBOT. In conclusion, one should take coronary artery disease and stroke history into consideration because of their possible negative effect on expected outcome.
Microvascular complications are other comorbidities that affect wound healing of patients with diabetes. The current study evaluated the relationships of HBOT outcomes to neuropathy, nephropathy, and retinopathy.
Although neuropathy was not shown to affect the outcomes significantly, the quality of this argument is poor. A strong association with both diabetic foot ulceration and lower extremity amputation has been demonstrated with chronic kidney disease and end-stage renal disease [26, 27] . In the current study, interestingly there was not a significant relationship to chronic kidney disease or endstage renal disease. Despite a small amount of missing data on retinopathy, the researchers have demonstrated that HBOT outcomes were significantly better when retinopathy was at a background stage and poorer when it progressed (P = 0.022, Table 4 ). One might hypothesize that the progression of retinopathy might be an early and more valuable marker when discussing about the effect of HBOT on wound healing. These data should be taken to consideration in further trials as they can provide clues about the mechanism of the effect of HBOT on microcirculation which may facilitate wound healing.
A long-term analysis of the effect of HBOT on ischemic diabetic ulcers has shown that the benefit of HBOT seemed to persist after discontinuing the therapy [9, 10] . These results may greatly depend on the effect of angiogenesis [8] . In accordance with this, there were no statistically significant differences of the favorable outcomes compared with the 12-month follow-up results excluding patients who passed away within this period ( Table 2) .
Patients' characteristics such as age, diabetes duration and HbA1c were not shown to be related to the outcomes, contrary to expectations. This might be due to the complexity of the other factors such as comorbidities and the extent of PAD which were shown to primarily affect healing [1] . A lack of a reliable assessment of the neuropathy was a limitation of this study.
Diabetic foot off-loading techniques were applied very poorly both before and with HBOT. Retinopathy could have not been evaluated in all patients. Transcutaneous oxygen pressure (TcPO2) measurements which may have been valuable were not made.
Diabetic foot should be considered a sign of multi-organ disease. Therefore, before a decision about HBOT has been reached, an overall understanding of the patients' condition of diabetes, as well as the wound, is required.
The current study demonstrates that histories of coronary artery disease or stroke, and advanced retinopathy worsen the outcomes of HBOT significantly. The results also revealed that PAD at the femoral level should be first considered for surgery, but PAD below the knee seems not to be an obstacle to the effect of HBOT in the treatment of diabetic foot.
